Free Trial

Omega Healthcare Investors, Inc. (NYSE:OHI) Holdings Boosted by Wright Investors Service Inc.

Omega Healthcare Investors logo with Finance background

Wright Investors Service Inc. grew its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 31.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 66,284 shares of the real estate investment trust's stock after purchasing an additional 15,814 shares during the quarter. Wright Investors Service Inc.'s holdings in Omega Healthcare Investors were worth $2,698,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in OHI. Cibc World Markets Corp acquired a new stake in Omega Healthcare Investors in the fourth quarter worth $2,489,000. Waterloo Capital L.P. bought a new stake in Omega Healthcare Investors in the 4th quarter valued at about $2,380,000. EHP Funds Inc. acquired a new position in Omega Healthcare Investors during the 4th quarter valued at about $227,000. Verition Fund Management LLC grew its position in Omega Healthcare Investors by 5,224.5% in the 4th quarter. Verition Fund Management LLC now owns 524,201 shares of the real estate investment trust's stock worth $16,072,000 after purchasing an additional 514,356 shares during the last quarter. Finally, Left Brain Wealth Management LLC increased its stake in shares of Omega Healthcare Investors by 2.0% in the fourth quarter. Left Brain Wealth Management LLC now owns 17,365 shares of the real estate investment trust's stock valued at $532,000 after purchasing an additional 335 shares during the period. 65.25% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on OHI. Mizuho lowered Omega Healthcare Investors from an "outperform" rating to a "neutral" rating and increased their price objective for the stock from $34.00 to $35.00 in a report on Thursday, July 25th. Scotiabank raised their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "sector perform" rating in a report on Monday, August 26th. Wells Fargo & Company reaffirmed an "overweight" rating and issued a $43.00 price objective (up previously from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday. Finally, Truist Financial raised their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "hold" rating in a research note on Wednesday, September 4th. Seven equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $36.00.

Get Our Latest Analysis on Omega Healthcare Investors

Insider Transactions at Omega Healthcare Investors

In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of the business's stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the sale, the chief financial officer now owns 183,076 shares of the company's stock, valued at $7,357,824.44. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In related news, COO Daniel J. Booth sold 56,725 shares of the firm's stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the transaction, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of the business's stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the sale, the chief financial officer now directly owns 183,076 shares in the company, valued at approximately $7,357,824.44. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is owned by insiders.

Omega Healthcare Investors Stock Down 1.6 %

Omega Healthcare Investors stock traded down $0.63 during trading hours on Friday, hitting $39.35. The company had a trading volume of 1,556,545 shares, compared to its average volume of 1,685,377. The firm's fifty day moving average is $39.10 and its 200-day moving average is $34.61. The company has a debt-to-equity ratio of 1.19, a current ratio of 5.79 and a quick ratio of 5.79. Omega Healthcare Investors, Inc. has a fifty-two week low of $27.53 and a fifty-two week high of $41.53. The firm has a market capitalization of $9.72 billion, a P/E ratio of 35.44, a price-to-earnings-growth ratio of 1.30 and a beta of 1.00.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last announced its quarterly earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 EPS for the quarter, missing the consensus estimate of $0.65 by ($0.20). The firm had revenue of $252.70 million during the quarter, compared to the consensus estimate of $205.92 million. Omega Healthcare Investors had a net margin of 33.52% and a return on equity of 8.61%. The company's quarterly revenue was up 17.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.74 EPS. On average, research analysts forecast that Omega Healthcare Investors, Inc. will post 2.69 earnings per share for the current year.

Omega Healthcare Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Monday, August 5th were given a $0.67 dividend. The ex-dividend date was Monday, August 5th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.81%. Omega Healthcare Investors's dividend payout ratio is currently 241.44%.

Omega Healthcare Investors Company Profile

(Free Report)

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.

Recommended Stories

Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report).

Institutional Ownership by Quarter for Omega Healthcare Investors (NYSE:OHI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Omega Healthcare Investors right now?

Before you consider Omega Healthcare Investors, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.

While Omega Healthcare Investors currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Tesla Stock: Profits vs. Price—Is It Time to Sell?

Tesla Stock: Profits vs. Price—Is It Time to Sell?

Find out why some believe it might be time to move on from Tesla stock, while others still see potential in its long-term growth.

Related Videos

Top Stocks to Buy, Sell, and Hold Right Now
Tesla Stock Dip: A Buyer’s Alert
Opportunities Arise as Stock Market Rotates from Big Tech

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines